4//SEC Filing
Wong Hing C 4
Accession 0000950170-25-075259
CIK 0001828673other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:35 PM ET
Size
5.1 KB
Accession
0000950170-25-075259
Insider Transaction Report
Form 4
Wong Hing C
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2025-05-16$7.45/sh+8,054$60,002→ 501,911 total
Footnotes (1)
- [F1]These shares were issued pursuant to a conversion of Unsecured Convertible Promissory Notes which were issued to six holders through a Company financing of an aggregate principal of $270,000 in one-year Notes. The Notes contained a mandatory conversion provision, which resulted in the Notes converting into shares of common stock at a mandatory conversion price of $7.45 per share as set by the registered offering. The Notes converted after the closing of the Company's registered offering on May 15, 2025. The conversion transaction also included an allocated portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company.
Documents
Issuer
HCW Biologics Inc.
CIK 0001828673
Entity typeother
Related Parties
1- filerCIK 0001866258
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 4:35 PM ET
- Size
- 5.1 KB